Prime Behavior Testing Laboratories Inc. is a US-based company that serves to assist clients with the testing and evaluation of novel therapeutic agents and to identify products that may be suitable for clinical trials in an efficient and cost-effective manner. We specialize in cognition testing (Learning, Memory, and Attention) in rodent and Non-Human Primates (NHPs).
We help identify products that may be suitable for clinical trials.
We test the efficacy of novel therapeutics for cognitive and psychiatric disorders. We also test drugs for abuse potential and abuse prevention.
We specialize in cognitive testing (Learning, Memory, and Attention)
Tests on rodent and Non-Human Primates are overseen by a full-time academic who runs the small animal core facility. We stay current due to ongoing scientific research studies in animal behavior.
PBTLI is unique from most other clinical research organizations - we provide specialized attention and cater our research specifically to your company's needs.
-
1
Qualified Staff
Our staff consists of highly trained animal behavior technicians, some with 20+ years of industry experience. -
2
Academic Affiliation
PBTLI is affiliated with the Animal Behavior Center at Augusta University. -
3
Well Published
We continually produce new scientific literature and publish in top, peer reviewed scientific journals. This underscores our emphasis on innovation and new science.
-
4
Focused Facility
We are a smaller facility; however, we focus on customer service, efficiency, and reliability. -
5
Wide Range of Services
While we specialize in animal behavior, we can provide the most basic (e.g., cell-culture) evaluations to pre-clinical NHP testing and scientific advising. -
6
Results You Can Trust
We will provide a frank, honest, and unbiased assessment of your novel therapeutic agent or technology. We can provide detailed SOPs for all of the services we offer and have a large database of positive control compounds for efficacy comparisons.
Latest News
-
New Journal Article Published:
Aged rhesus monkeys: Cognitive performance categorizations and preclinical drug testing
Published: 2021 Apr 1Abstract: Rodent models have facilitated major discoveries in neurobiology, however, the low success rate of novel medications in clinical trials have led to questions about their translational value in neuropsychiatric drug development research. For age-related disorders of cognition such as Alzheimer’ disease (AD) there is interest in moving beyond transgenic amyloid-β and/or tau-expressing rodent models and focusing more on natural aging and dissociating “healthy” from “pathological” aging to identify new therapeutic targets and treatments. In complex disorders such as AD, it can also be argued that animals with closer neurobiology to humans (e.g., nonhuman primates) should be employed more often particularly in the later phases of drug development. The purpose of the work described here was to evaluate the cognitive capabilities of rhesus monkeys across a wide range of ages in different delayed response tasks, a computerized delayed match to sample (DMTS) task and a manual delayed match to position (DMTP) task...